跳至主要内容
临床试验/DRKS00032868
DRKS00032868招募中Unknown

Suitability of fMRI for detecting a therapeutic effect of dapagliflozin in patients with advanced renal insufficiency or after kidney transplantation - Dapagliflozin_fMRI

Medizinische Universitätsklinik Tübingen, Innere Medizin IV, Abteilung für Diabetologie, Endokrinologie, Nephrologie0 个研究点目标入组 60 人开始时间: 2023年11月15日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Participation in the study The RENAL LIFECYCLE Trial: A RCT to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Out-comes in Patients With Severe CKD” (ClinicalTrials.gov Identifier: NCT05374291) in Tübingen,
  • written consent from the patient.

排除标准

  • Presence of non-MRI-compatible implants or any type of metal in and on the body,
  • increased sensitivity to loud noises,
  • claustrophobia,
  • obesity with a body weight of >150 kg,
  • pregnant/breastfeeding women,
  • limited ability to consent,
  • patients who do not want to be informed about incidental findings.

研究者

发起方
Medizinische Universitätsklinik Tübingen, Innere Medizin IV, Abteilung für Diabetologie, Endokrinologie, Nephrologie

相似试验